Targeted Oncology58m
Considering 3-Year Follow-Up Data of Cilta-Cel in Multiple Myeloma
Samer A. Al’Hadidi, MD, discusses the follow-up data for ciltacabtagene autoleucel in patients with multiple myeloma.
Hosted on MSN1h
Edo assets committee uncovers N200bn road contract debt by Obaseki
The Edo Assets Verification Committee says it has uncovered some irregularities in the award of contracts, including an N200 ...